Literature DB >> 12195299

Pseudophosphorylated prolactin (S179D PRL) inhibits growth and promotes beta-casein gene expression in the rat mammary gland.

C Benson Kuo1, Wei Wu, Xiaolei Xu, Lili Yang, Cyndi Chen, Djurdjica Coss, Ben Birdsall, Dorsa Nasseri, Ameae M Walker.   

Abstract

We have investigated the individual roles of unmodified prolactin (U-PRL) and a mimic of phosphorylated PRL (S179D PRL) in mammary development. Recombinant versions of the PRLs were delivered to rats throughout pregnancy at a rate of 6 microg/24 h per rat and to non-pregnant females at a rate of 24 microg/24 h per rat. Measurement of progesterone, corticosterone, and estradiol showed no effect of the administered PRLs on the levels of these other mammotropic hormones. Histological and morphometric analysis showed U-PRL to cause mammary growth, whereas S179D PRL inhibited growth. Molecular analysis demonstrated decreased beta-casein expression in the mammary glands of the U-PRL-treated animals at term and increased beta-casein expression in the mammary glands of the S179D PRL-treated animals. Superior beta-casein gene expression in response to S179D PRL versus U-PRL was confirmed in HC11 cells. We conclude that U-PRL is important for growth, whereas S179D PRL promotes at least one measure of differentiated function in the mammary gland.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12195299     DOI: 10.1007/s00441-002-0598-8

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  11 in total

Review 1.  Paradigm-shifters: phosphorylated prolactin and short prolactin receptors.

Authors:  KuangTzu Huang; Eric Ueda; YenHao Chen; Ameae M Walker
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

2.  New homologous bioassays for human lactogens show that agonism or antagonism of various analogs is a function of assay sensitivity.

Authors:  Sophie Bernichtein; Sébastien Jeay; Roland Vaudry; Paul A Kelly; Vincent Goffin
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

3.  Prolactin-mediated regulation of lipid biosynthesis genes in vivo in the lactating mammary epithelial cell.

Authors:  Michael C Rudolph; Tanya D Russell; Patricia Webb; Margaret C Neville; Steven M Anderson
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-04-05       Impact factor: 4.310

4.  A mimic of phosphorylated prolactin inhibits human breast cancer cell proliferation via upregulation of p21 waf1.

Authors:  Wenjie Xie; Yan He; Da Huo; Yafang Huang; Wei Wu
Journal:  Med Oncol       Date:  2009-12-15       Impact factor: 3.064

Review 5.  Historical perspectives of prolactin and growth hormone as mammogens, lactogens and galactagogues--agog for the future!

Authors:  Josephine F Trott; Barbara K Vonderhaar; Russell C Hovey
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-19       Impact factor: 2.673

6.  Bioactive prolactin levels and risk of breast cancer: a nested case-control study.

Authors:  Shelley S Tworoger; Megan S Rice; Bernard A Rosner; Yvonne B Feeney; Charles V Clevenger; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-14       Impact factor: 4.254

Review 7.  Prolactin regulation of mammary gland development.

Authors:  Samantha R Oakes; Renee L Rogers; Matthew J Naylor; Christopher J Ormandy
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

8.  Common and specific effects of the two major forms of prolactin in the rat testis.

Authors:  Valencia L Williams; Ariel DeGuzman; Hong Dang; Mitsumori Kawaminami; Timothy W C Ho; David G Carter; Ameae M Walker
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-10-02       Impact factor: 4.310

Review 9.  S179D prolactin: antagonistic agony!

Authors:  Ameae M Walker
Journal:  Mol Cell Endocrinol       Date:  2007-06-28       Impact factor: 4.102

10.  S179D prolactin diminishes the effects of UV light on epidermal gamma delta T cells.

Authors:  Esther A Guzmán; John L Langowski; Ariel De Guzman; H Konrad Muller; Ameae M Walker; Laurie B Owen
Journal:  Mol Cell Endocrinol       Date:  2007-09-11       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.